http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106748950-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_73d882e858fb2c92134460ecbeabdb4e
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-07
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-27
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-27
filingDate 2017-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c17b99c01148d9566125f94bad39478d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f109a93969a5b2d8394c1edd37b6a17d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b0a847b673ae369818da88a7e786ce0
publicationDate 2017-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-106748950-A
titleOfInvention A kind of preparation method of buvaracetam and its intermediate
abstract The invention discloses a preparation method of a Buvaracetam intermediate shown in B-VI, comprising the following steps: dissolving B-IV and R-phenethylamine in a solvent, crystallizing, filtering, and recrystallizing to obtain B ‑V, which converts to B‑VI. In the preparation process of the present invention, no chiral chromatographic column is needed to separate the isomers, and only simple steps such as extraction, washing, drying, and concentration can be used to separate the effective components. The separation process is simple, and the production cost of brivaracetam is greatly reduced.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107337628-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107337628-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11518741-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112955430-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112955430-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115340482-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112020498-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111154735-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108147988-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11498897-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109655557-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108548873-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021253162-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020125536-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115010640-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019242192-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111579706-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019157856-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021217579-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3778568-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111333563-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113045468-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109852644-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109852644-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109593055-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109593055-A
priorityDate 2017-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106279074-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105130879-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467744304
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163897185
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465640961
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422658541
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID59650074

Total number of triples: 47.